Acute kidney injury from immune checkpoint inhibitor use

Immune checkpoint inhibitors are novel oncological medications, current classes of which include monoclonal antibodies that target inhibitory receptors cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), programmed death 1 protein (PD-1) and programmed death-ligand 1. While they are novel in their...

全面介紹

Na minha lista:
書目詳細資料
發表在:BMJ Case Rep
Main Authors: Gordon, Lexis, Dokouhaki, Pouneh, Hagel, Kimberly, Prasad, Bhanu
格式: Artigo
語言:Inglês
出版: BMJ Publishing Group 2019
主題:
Findings That Shed New Light on the Possible Pathogenesis of a Disease or an Adverse Effect
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6827794/
https://ncbi.nlm.nih.gov/pubmed/31653633
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-231211
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍